Center for Psychedelic Research
On the cutting edge of research
PSYCHEDELICS RESEARCH DIVISION
Segal Trials is pioneering as the first private research facility in Florida to offer psychedelic research and paving the way for advancements in medicine for the world. Offering a full-service center dedicated to Psychedelics Research. With state-of-the-art equipment in a relaxed and comfortable setting to accommodate the clinical research participants. The doctors and staff are experts in psychedelics research and are passionate about patient care
MILESTONES
We are a leading Site Network focused on advancing medicine for current and future generations serving Miami-Dade and Broward counties.
- First private research sites in the U.S. to conduct studies involving Psychedelics
- First patient dosed in the first LSD trial in over 40+ years
- One of the first private sites to conduct a study with psychedelics with an IND in the United States
- Database of over 3000+ patient referrals received for potential participation in psychedelic trials
- Dissociated drugs & psychedelics since 2012
- Construction / Design of dosing rooms and conduct dosing sessions
- Dr. Kakar was one of the first private researchers in the U.S. to obtain a DEA Schedule 1 license
- Specialized Phase I-IV outpatient research site dedicated to psychedelic, cannabis, & dissociative drug trials
- Specialized regulatory experience needed to obtain and manage a DEA schedule 1 license
- Described as the "gold standard" in the design and construction of dosing and sessions rooms
- Highly trained facilitators augmented by a well-established team of research professionals and innovative recruitment experts
- Multiple dosing rooms with on-suite bathrooms
Psychedelic Research Studies
Segal Trials is currently offering Psychedelic research studies. If you would like to participate, please contact us for more information.
TESTIMONIALS
“Segal Trials is one of the few places I believe is doing everything they can to advance the future of mental health. This past year I enrolled in a psychedelic study that studied the effects of LSD on Generalized Anxiety Disorder. I have to say that my experience before, during, and after this study was nothing short of exceptional. I was treated so well by the staff here. They made themselves available to me whenever I needed them. They worked with MY schedule. They fully educated me on what I was getting myself into. Most importantly they never pressured me to do anything and I felt like the choice was always MINE wether I wanted to proceed or not. I can honestly say that participating in this study changed my life for the better. If I could do it all over again I would a million times. If you’re skeptical about doing business with these people I’d say go for it. You WILL have an amazing experience along the way and meet some pretty cool people. A special thank you go out to Sarah & Scott for facilitating my session and being there for me every step of the way. Y’all rock!!!”
MEET THE EXPERTS: Psychedelic Studies Clinical Team
Center for Psychedelics Research specializes in Phase I-IV outpatient research dedicated to psychedelic, cannabis, and dissociative drug trials. The highly trained facilitators are supported by a well-established team of research professionals, along with innovative recruitment experts. Dr. Kakar was one of the first private researchers in the U.S. to obtain a DEA Schedule license. This specialized regulatory experience is required to obtain and manage DEA schedule 1 license.
Dr. Rishi Kakar
Chief Scientific Officer • Medical Director and Principal Investigator • Board Certified Psychiatrist • Diplomate, American Board of Psychiatry and Neurology
Dr. Scott Fisher
Lead Psychedelics Therapist
Dr. Eva Nowakowski Sims
Psychedelics Therapist
How does a Psychedelic Research Study work?
Do you want to Participate?
Apply now and check to see if you qualify!
Segal Trials is currently offering Psychedelic research studies. If you would like to participate, please contact us for more information.
Treatment Resistant Depression Study
Study Details:
- Men and women 18 years or older
- Diagnosed with Major Depression & past medications have failed
- Currently taking an antidepressant
- Have not been diagnosed with the following: Bipolar, Schizophrenia, PTSD, OCD, Anorexia Nervosa
Healthy Volunteers Study
Study Details:
- Men and women 18 years or older
- Diagnosed with Major Depression & past medications have failed
- Currently taking an antidepressant
- Have not been diagnosed with the following: Bipolar, Schizophrenia, PTSD, OCD, Anorexia Nervosa
